Drugs with blocking effects on the renin-angiotensin-aldosterone system do not improve endothelial dysfunction long-term in hypertensive patients

Journal of International Medical Research

Volumn 37, Issue 4, 2009, Pages 996-1002

  Sozen, Ahmet Bilge ^a   Kayacan, M S ^a   Tansel, T ^a   Celebi, A ^b   Kudat, H ^a   Akkaya, V ^a   Erk, O ^a   Hatipoglu, I ^a   Demirel, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Taksim State Hospital   (Turkey)

Author keywords

Endothelial dysfunction; Endothelium independent vasodilation; Endothelium dependent vasodilation; Essential hypertension; Renin angiotensin aldosterone system blocking drugs

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; HEMOGLOBIN; HYDROCHLOROTHIAZIDE; IRBESARTAN; QUINAPRIL; URIC ACID; VALSARTAN; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MALE; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION; ADULT; BLOOD PRESSURE; BRACHIAL ARTERY; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRACHIAL ARTERY; CHRONIC DISEASE; DIURETICS; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME; VASODILATION;

EID: 70350497096     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700403     Document Type: Article

References (18)

1. Panza JA, Quyyumi AA, Brush JE, et al: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27. (Pubitemid 20209468)
2. Linder L, Kiowski W, Bühler FR, et al: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990; 81: 1762-1767. (Pubitemid 20183824)
3. Perticone F, Ceravolo R, Pujia A, et al: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196. (Pubitemid 32655837)
4. Modena MG, Bonetti L, Coppi F, et al: Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40: 505-510. (Pubitemid 34833167)
5. Schiffrin EL: Vascular remodeling and endothelial function in hypertensive patients: effects of antihypertensive therapy. Scand Cardiovasc J 1998; 47: 15-21. (Pubitemid 28105219)
6. Higashi Y, Sasaki S, Nakagawa K, et al: A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study. J Am Coll Cardiol 2000; 35: 284-291. (Pubitemid 30125515)
7. Von zur Mühlen B, Kahan T, Haegg A, et al: Treatment with irbesartan or atenolol improves endothelial function in essential hypertension. J Hypertens 2001; 19: 813-818.
8. On YK, Kim CH, Oh BH, et al: Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. Hypertens Res 2002; 25: 365-371. (Pubitemid 34752555)
9. Muiesan ML, Salvetti M, Monteduro C, et al: Effect of treatment on flow-mediated vasodilation of the brachial artery in essential hypertension. Hypertension 1999; 33: 575-580. (Pubitemid 29065723)
10. Ghiadoni L, Magagna A, Versari D, et al: Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41: 1281-1286. (Pubitemid 36706078)
11. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
12. Anderson TJ, Uehata A, Gerhard MD, et al: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
13. Corretti MC, Anderson TJ, Benjamin EJ, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
14. Ruggenenti P, Fassi A, Ilieva AP, et al for the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators: Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351: 1941-1951.
15. Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators: Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782-788.
16. Panza JA, Quyyumi AA, Callahan TS, et al: Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993; 21: 1145-1151. (Pubitemid 23106189)
17. Rossing K, Schjoedt KJ, Jensen BR, et al: Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 2005; 68: 1190-1198. (Pubitemid 43246436)
18. Schmieder RE, Klingbeil AU, Fleischman EH, et al: Additional antiproteinuric effect of ultrahigh dose candesartan: a doubleblind, randomized, prospective study. J Am Soc Nephrol 2005; 16: 3038-3045.